Pfizer has a second FDA approval for a migraine therapy stemming from its $11.6 billion Biohaven takeover, getting the go-ahead for intranasal therapy Zavzpret to sit alongside its fast-growing ...
Hosted on MSN1mon
CGRP Inhibitors for Migraine TreatmentAdditionally, Nurtec, Ubrelvy (ubrogepant), and Zavzpret (zavegepant)—a nasal spray—are approved for acute treatment of migraine headaches. CGRP is a protein present in the trigeminal nerve ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback